Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinic Receptor Genetic Variation and Alcohol Reward
NCT03294460Phase 1Recruiting
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Jun 2019
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by National Institute on Alcohol Abuse and Alcoholism. Primary endpoints: Blood-Oxygen-Level-Dependent response during the Alcohol-Food Incentive Delay (AFID) task at 3 hours and Breath Alcohol Concentration exposure at 3 hours. Started Jun 2019; status: recruiting.
Beyond the preview
Go deeper on NCT03294460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03294460.